PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 18425640-2 1998 After incubation with 200 U/mL IL-12 for 48 h, DNA synthesis of FBL-3 cells in S phase decreased significantly; the expression of CD14 which is the specific marker of monocyte increased, the rate of NBT(+) cells was apparently higher than that of the untreated FBL-3 cells. Nitroblue Tetrazolium 199-202 CD14 molecule Homo sapiens 130-134 21086135-7 2010 In addition, in cells induced to differentiate by ATRA or VD3, Nitroblue-tetrazolium (NBT) reduction and esterase activity, were blocked either by LY294002, a PI3K inhibitor, or by BIM, a PKC inhibitor, without affecting cell surface markers such as CD11b or CD14. Nitroblue Tetrazolium 86-89 CD14 molecule Homo sapiens 259-263 12677525-3 2003 The ability of HL-60 cells to reduce nitroblue tetrazolium (NBT) was significantly increased after APC treatment for 72 h. In these differentiating HL-60 cells, cell surface differentiation markers CD11b (for myeloid cells) and CD14 (for monocytic cells) were detected in 90.3 % and 70.1 % of the cells, respectively. Nitroblue Tetrazolium 37-58 CD14 molecule Homo sapiens 228-232 12677525-3 2003 The ability of HL-60 cells to reduce nitroblue tetrazolium (NBT) was significantly increased after APC treatment for 72 h. In these differentiating HL-60 cells, cell surface differentiation markers CD11b (for myeloid cells) and CD14 (for monocytic cells) were detected in 90.3 % and 70.1 % of the cells, respectively. Nitroblue Tetrazolium 60-63 CD14 molecule Homo sapiens 228-232